Related Experiment Videos
[Fungal infections of the eye--current antifungal agents]
Agnieszka Samsel1, Jadwiga Meszaros
1Katedry i Kliniki Chorób Oczu Akademii Medycznej, Warszawie.
Klinika Oczna
|August 15, 2002
Abstract:
Antifungal agents used in ocular infections are presented. The most common etiology of fungal infections is described. Mechanisms and range of action, available drugs and the latest groups of antifungal agents during clinical trials are presented.
Insights
This review covers antifungal agents for ocular infections, detailing common causes, mechanisms, and available treatments. It also highlights emerging antifungal drugs currently in clinical trials for eye infections.
Area of Science:
- Ophthalmology
- Mycology
- Pharmacology
Context:
- Fungal infections of the eye (ocular mycoses) represent a significant cause of visual impairment and blindness globally.
- Accurate diagnosis and timely treatment are crucial to prevent irreversible vision loss.
Purpose:
- To provide a comprehensive overview of antifungal agents used in treating ocular infections.
- To describe the common etiologies of fungal eye infections.
- To review the mechanisms of action, spectrum of activity, and current therapeutic options, including agents in clinical development.
Summary:
- The review details the most frequent causes of fungal keratitis and endophthalmitis.
- It discusses established antifungal drugs, their pharmacodynamics, and clinical applications in ophthalmology.
- Emerging antifungal agents undergoing clinical trials are also presented, offering insights into future treatment strategies.
Impact:
- This information aids ophthalmologists and infectious disease specialists in selecting appropriate antifungal therapies for ocular mycoses.
- Understanding new treatment modalities can improve patient outcomes and reduce the burden of fungal eye infections.
- Facilitates informed decision-making in managing complex and sight-threatening ocular fungal diseases.